SUSAN E. KNIGHT - 08 Feb 2024 Form 4 Insider Report for SURMODICS INC (SRDX)

Role
Director
Signature
/s/ John D. Manders, on behalf of Susan E. Knight
Issuer symbol
SRDX
Transactions as of
08 Feb 2024
Net transactions value
$0
Form type
4
Filing time
12 Feb 2024, 16:10:17 UTC
Previous filing
07 Feb 2024
Next filing
28 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRDX Common Stock Award $0 +1,944 +5.9% $0.000000 35,148 08 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRDX Stock Option (right to buy) Award $0 +4,155 $0.000000 4,155 08 Feb 2024 Common Stock 4,155 $31.89 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount beneficially owned includes 17,286 restricted stock units (RSUs) that vest on service-based vesting dates that will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
F2 The stock options vest ratably on a monthly basis and become fully vested on February 8, 2025, the 12-month anniversary of the grant date.